Menu ×

HEALTHCARE & PHARMACEUTICAL

3D Printed Drugs Market Analysis by Technology (Inkjet Printing, Zipdose Technology, Stereolithography); by Application (Orthopedic, Neurology); and by End User (Hospitals, Clinics and Research Laboratories) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033

  • Report ID: 421
  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

IN THE NEWS

  • Pacira Pharmaceuticals Inc and sevredent sourcing solutions partnered to provide exparel to patients undergoing oral and maxillofacial treatments

  • Affinity Therapeutics raised USD 175 million for the development of engineered T cell therapies for cancers that are difficult to treat. The launch is one of the biggest biotech launches of the year.

Global 3D Printed Drugs Market Highlights Over 2023 - 2033

Base Year

2022

Forecast Year

2023-2033

CAGR

~7%

Base Year Market Size (2022)

~ USD 280 Million

Forecast Year Market Size (2033)

~ USD 530 Million

 

The global 3D printed drugs market is estimated to garner a revenue of ~USD 530 Million by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 280 Million in the year 2022. The growth of the market can be attributed primarily to the rising 3D printing of pharmaceuticals. For instance, 3D printing of pharmaceuticals have increased year on year Valued at USD 174 million in 2020 and anticipated to grow to USD 28 million by 2025. In 2020, the 3D printing of pharmaceuticals accounted for USD 174 million and is expected to reach USD 28 million by 2025. There is an opportunity to capitalize on the benefits and overcome the challenges associated with 3D printing of pharmaceuticals.

3d printed drug market overview image Get more information on this report:Download Sample PDF

Powder-liquid three-dimensional (3DP) printing technologies are used to develop 3D printed drugs. By using an aqueous fluid, different layers of powder can be bonded and multiple products can be produced. Three-dimensional powder-liquid drugs or pills are comparatively more soluble than two-dimensional drugs or pills. Furthermore, 3D printed drugs are able to dissolve insoluble compounds such as silver chloride very easily. 3D printed high dose drugs can also be dissolved within seconds, making them more acceptable. As well as this, 3D-printed drugs are comparatively reliable pills when taken at the right dosage. Moreover, rising number of chronic diseases, rising adoption of technological advancements, advantages of 3D printed drugs over general drugs such as low cost and better solubility along with, growing demand for self-medication. For instance, approximately 90% of surgical and medical wards have policies allowing patients to self-administrate.  

Global 3D Printed Drugs Market: Growth Drivers and Challenges

Growth Drivers

  • Rising Prevalence Of Diseases Among Children Such As Pneumonia -For instance, approximately 2,000 children are killed by pneumonia every day, which is more than any other infectious disease. More than 200,000 of them are newborns.Taking medication could therefore become much easier for children who are resistant to taking the medication they need owing to 3D printed drugs. The first benefit of these tablets is that they may be able to choose the shape, color and design of the tablet, as well as its taste. The increasing number of diseases among children are contributing to the increased adoption of these drugs, which is anticipated to drive global 3D printed drugs market over the forecast period.

  • Increase In Research And Development Expenditures- As per World Bank data, global research and development expenditures contributed 2.63% to GDP in 2020. Compared to 2018, this represents a considerable increase from 2.2%.

  • A Global Increase In Healthcare Spending- Approximately 19.7% of the nation's GDP was accounted for by healthcare expenditures in 2020, according to a report released by the Centers for Medicare & Medicaid Services. 

  • Growing Incidence of Non Communicable Diseases- Worldwide, noncommunicable diseases (NCDs) cause 41 million deaths each year, accounting for 74% of all deaths. It is estimated that 17 million people die of a NCD before they reach 70 years of age every year; 86% of these premature deaths happen in countries with low and middle incomes.

  • Global Increase In Geriatric Population- The World Bank recently reported that 747,238,580 people over 60 years of age lived worldwide at the end of 2021. Future projections predict a rise in the number.

Challenges

  • Unapproval Of 3D Printed Drugs In Many Countries
  • Drug Shortages Due To COVID-19 
  • Inadequacies In Government Regulations Regarding 3D Printing

The global 3D printed drugs market is segmented and analyzed for demand and supply by technology into inkjet printing, zipdose technology, and stereolithography. Among these segments, the zipdose technology segment is anticipated to capture the largest market size in the global 3D printed drugs market owing to the rise in the number of people suffering from dysphagia. It was observed that the prevalence of dysphagia in hospitalized patients ranges from 15% to 17%. Approximately 31% to 59% of nursing home residents suffer from dysphagia symptoms. In addition to being easy to use, this makes swallowing the drugs easier and proves to be effective for patients with dysphagia. Moreover, the growing demand for quickly dispersible drugs among geriatric and pediatric patients is expected to augment segment growth over the forecast period.

Major Macro-Economic Indicators Impacting the Market Growth

3d printed drug market expenditure graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global 3D Printed Drugs Market Regional Synopsis

Regionally, the global 3D printed drugs market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2033 owing to the growing incidence of chronic diseases and increasing health awareness among people. For instance, 44% of the population suffers from at least one chronic illness, which amounts to over 132 million Americans. Over 1.6 million Americans die every year from chronic diseases in the United States. Furthermore, the well-developed domestic healthcare infrastructure, extensive research and development, and increasing technological advancements in the North America region are anticipated to drive the regional market growth over the forecast period.

3d printed drug market share image  Get more information on this report:Download Sample PDF

The global 3D printed drugs market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global 3D printed drugs market includes the following segments:

          By Technology

  • Inkjet Printing
  • Zipdose Technology
  • Stereolithography

          By Application

  • Orthopedic
  • Neurology

 

           By End User

  • Hospitals
  • Clinics
  • Research Laboratories

Top Featured Companies Dominating the Global 3D Printed Drugs Market

  • Extend Biosciences

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Bioduro
  • Affinity Therapeutics
  • Osmotica Pharmaceuticals
  • Acrux
  • Thiomatrix
  • Ico Therapeutics Inc.
  • Formac Pharmaceuticals
  • BiopharmX
  • Pacira Pharmaceuticals Inc.

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved